Table 1.

Study visits

Study visit	1	2	3	4	5	6	7	8	9	10	11	12	13	14	15	16	17
Weeks from randomisation			−3	−2	−1	0	1	~7	11	12	13	23	24	25	26	26	39
Clinical assessment	X					X					X					X
Time with health professional		X	X	X	X	X	X	X	X	X	X	X	X	X	X	X
HbA1c	X					X					X					X
β-hCG, C-peptide	X
CHO counting education		X									X
Insulin pump training							X
Insulin dose review		X						X			X					X
Logbook provision			X
Logbook data collection				X	X	X	X	X	X	X	X	X	X	X	X	X
Masked CGM insertion			X	X	X				X	X		X	X	X
Glucose metre upload				X	X	X	X	X	X	X	X	X	X	X	X	X
Psychosocial, sleep, cognitive functioning surveys	X										X					X
Cognitive performance device provision			X						X			X
Actigraphy and sleep diary provision			X	X	X				X	X		X	X	X
Semistructured interviews							X		X							X	X
Driving device and diary provision			X	X	X				X	X		X	X	X
Holter monitor provision			X						X			X
Vascular disease risk markers						X										X

CGM, continuous glucose monitoring; CHO, carbohydrate.